Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 3rd World Conference on Breast and Cervical Cancer Abu Dhabi, UAE.

Day 2 :

Keynote Forum

Yan Gao Man

International Union for Difficult-to-treat Diseases, USA

Keynote: The most updated theory with supporting data for cancer invasion and metastasis

Time : 09:30-10:30

OMICS International BreCeCan 2018 International Conference Keynote Speaker Yan Gao Man photo

Yan Gao Man is Co-Editor-in-chief of OncoMedicine, Publisher & editor-in-chief, New Approaches combating Cancer & Aging. Editor-in-chief, Journal of CancerVice President, South Hospital of Nanjing, Nanjing, China Consultant, The Health System of the Hunan Province, China Visiting Professor, China Key Laboratory of Subhealth Intervention Technology, Changsha, China Honorable Chairman, Chemotherapy Committee of Anti-cancer Association of Shanxi province, China Visiting Professor, China National Center of Colorectal Disease (Ranked #1 in China and Asian-Pacific region) Adjunct Distinguished Scientist, Hackensack University Medical Center, NJ, USA (one of 100 best US hospitals) Founder and Chairman of Board Directors and Secretary-General, International Union for Difficult-to-treat Diseases


There are two major hypotheses that explain the mechanism of tumor progression from in situ to stromal tumor invasion. One is the proteolytic enzymes theory which is based on the overproduction of MMPs by the myoepithelial cells and surrounding tumor cells and the other theory is known as focal myoepithelial cell layer disruption (FMCLD theory). Proteolytic enzymes theory—In order to invade the stroma and metastasize, tumor cells have to cross several barriers like BM, myoepithelial cell layer, interstitial tissues, and extracellular matrices, which are composed primarily of collagen, proteoglycans, laminin, elastin, and other glycoproteins. Tumor cells overexpress and secrete proteases which are capable of degrading the components of these barriers and thus facilitate their migration. According to the proteolytic enzyme theory, the progression from the in situ to the invasive stage is believed to be triggered by the overproduction of various proteolytic enzymes by the tumor cells, such as MMPs, serine proteases and cathepsins resulting in the degradation of the BM. Focal myoepithelial cell layer disruption (FMCLD) theory—recently, a new model of tumor invasion of stroma by the epithelial cells was proposed by Yan Man. According to this model, tumor invasion is triggered by a series of events which begin when the myoepithelial cells are damaged by any genetic abnormalities, inflammation, mutations, localized trauma or other physical/chemical injuries which result in the disruption of the myoepithelial cell layer or impairs the normal replacement process. In fact, it is now known that disruption in the myoepithelial cell layer is the most distinct sign of tumor invasion in breast cancer. FMCLD theory has some advantages over proteolytic theory because it focuses on the interaction of the different types of cells present in the tumor microenvironment. Focal breakdown of myoepithelial cell layer and BM at sites of white blood cell infiltration have also been observed in DCIS. Emphasizing the necessity of changes in both in “seed” and “soil” for progression, epithelial cell clusters overlying the disrupted myoepithelial layers were different from adjacent cells within the same duct with respect to ER (estrogen receptor) status, frequency or pattern of LOH and/or MSI, and expression of tumor progression-related genes, normal stem cell and proliferation markers, and showed invasion into the stroma and blood vessel-like structures. Since tumor-stromal interactions are bi-directional, identification of the initiating events requires further study.